Showing 1 - 10 of 156
Engaging and strengthening the ICDS and Health programs of the government was a major approach of the two component … effectiveness at scale. This paper describes how the INHP learnt and evolved in its strategies in engaging existing public health …
Persistent link: https://www.econbiz.de/10008502491
examination with the Committee on Health and Family Welfare On adulterated and spurious drugs …
Persistent link: https://www.econbiz.de/10005528115
The Task Force recommends that price regulation should be on the basis of ‘Essentiality’ of the drug and it should be applied only to formulations and not to upstream products, such as bulk drugs. No effort should be made to impose a uniform price, and only a ceiling price should be...
Persistent link: https://www.econbiz.de/10005528148
product patents for pharmaceuticals, this paper provides a rigorously-derived estimate of the possible impact of …-bacterials (i.e., antibiotics) in the Indian pharmaceuticals market. These estimates are then used to carry out counterfactual …
Persistent link: https://www.econbiz.de/10005528220
examination for pharmaceuticals inventions, particularly in developing countries. It proposes a set of general guidelines for the … health-sensitive guidelines for the evaluation and review of pharmaceutical patents at the national level. It examines the … practices of some patent offices and suggests some mechanisms that may be adopted to incorporate public health perspectives in …
Persistent link: https://www.econbiz.de/10005528232
This report analyzes the ITRIPS agreement. It discuses the problems and stakes, and consequences of this agreement. The report also provides case studies related to the topic and finally gives a suggestive conclusion.
Persistent link: https://www.econbiz.de/10005528311
While welcoming the move to withdraw the Report of the Technical Expert Group on Patent Law Issues AIDAN has issued a statement that the group must not be allowed to re-submit the report. The matter must be referred to a Parliamentary Standing Committee.
Persistent link: https://www.econbiz.de/10005528317
Rising drug prices and misuse of drugs: Calling Attention
Persistent link: https://www.econbiz.de/10005487581
Pharmaceuticals Policy, 2005 has been necessitated due to several developments that have taken place during the course of last few … several other matters having a close bearing on the pharmaceuticals sector have also been included in the policy. …
Persistent link: https://www.econbiz.de/10005487771
The focus of this paper is India. In line with TRIPS India has introduced a product patent regime in pharmaceuticals …
Persistent link: https://www.econbiz.de/10004988399